Information Provided By: 
Fly News Breaks for December 6, 2019
EW
Dec 6, 2019 | 07:33 EDT
Raymond James analyst Jayson Bedford raised his price target for Edwards Lifesciences to $263 from $255 following the company's annual Analyst Day. In a research note to investors, Bedford says that while the event "lacked sizzle" due to the absence of new market-moving information, he still came away encouraged with the strategy and remains confident in Edwards' position as one of the highest growth/quality companies in large cap healthcare. The analyst maintains an Outperform rating on the shares.
News For EW From the Last 2 Days
There are no results for your query EW
